Prof Langer will receive the award for his pioneering research that has led to the development of the first commercial mRNA vaccines
The 20th edition of BioAsia organised by the Government of Telangana has announced that the coveted Genome Valley Excellence Award for the year 2023 will be conferred upon Prof Robert S Langer, in light of his pioneering research that has led to the development of the first commercial mRNA vaccines used for a variety of infectious diseases.
Langer is currently the David H Koch Institute Professor at Massachusetts Institute of Technology (MIT), USA. He is also being acknowledged for his exemplary research in human health, including the detection, monitoring, and treatment of cancer. A veteran in his field, his remarkable contributions to biomedical and therapeutic research include developing long-term and controlled-release drug delivery systems used for a variety of applications including cancer therapy, insulin and vaccines.
As the director of the eponymous Langer Labs, he works at the intersection of biotechnology and material science and his research helped lay the foundation for the underlying delivery mechanism that led to the development of the first commercial mRNA vaccines. In 2010, he co-founded Moderna, the biotech company that came to prominence for developing an mRNA vaccine against COVID-19.
He is also prolific in the scientific community have authored more than 1,500 scientific papers, making him the most-cited engineer in history. In addition, he is also a serial entrepreneur being instrumental in starting more than 40 companies and is a recipient of numerous awards including the Queen Elizabeth prize for Engineering.
A distinguished jury of eminent figures of national and international reputation has made the final selection of the awardee. Speaking on the announcement of the 2023 Genome Valley Excellence Award, KT Rama Rao, Minister for Industries & Commerce, Government of Telangana said, “With the Genome Valley Excellence Award, we want to celebrate people who created an extraordinary impact within the Life Science community and there is no one who better fits the bill than Prof. Langer. BioAsia is honoured to present him with this award and celebrate his life’s work and its impact on the broader community now and for years to come.”
“Over the years, the Genome Valley Excellence Award has been presented to distinguished people who have made valuable contributions in the field of Life sciences and Public Health. And this year is no exception. We are proud to confer this award to Professor Robert Langer whose contributions including commercializing mRNA vaccine, drug delivery systems and tissue engineering has completely transformed the future landscape. His life and work are a source of inspiration to many and is a testament to keeping going and doing what a lot of people think is impossible and unattainable,” said Jayesh Ranjan, Principal Secretary (I&C), Government of Telangana.
“The Genome Valley Excellence award has gained an immense reputation benefitting from its extraordinary recipient history and is now regarded as one of the most prestigious awards. Robert ‘Bob’ Langer defines the word relentless and we are thrilled to welcome him to BioAsia 2023. A man of many hats – be it an Engineer, scientist, researcher or serial entrepreneur, he has truly made his mark and has changed the landscape of biotechnology for the generations to come. Having started and guided many companies, his entrepreneurial pursuits have been an extension of his research and unwavering commitment to serving mankind. Highlighting Prof. Langer and his work through this award should encourage the children of our community to be students of science and see firsthand, how pursuing science can create an impact and make a world of difference in the lives of many,” said Shakthi M Nagappan, CEO, BioAsia and Director of Lifesciences and Pharma, Government of Telangana.
